Thursday, July 8, 2010

Dr. Naritoku Appointed to Serve on Board of American Board of Clinical Pharmacology

Dr. Dean Naritoku, professor and chair of neurology at the University of South Alabama, was recently appointed to serve on the board of the American Board of Clinical Pharmacology. He will begin his term July 1, 2010.

Dr. Naritoku has close to 30 years of experience in academic medicine. Prior to joining USA, he served as professor and associate chair of neurology and director of the Center for Epilepsy at the Southern Illinois University (SIU) School of Medicine in Springfield, Ill.

At SIU, he also directed the office of therapeutics research and served as the fellowship director of clinical neurophysiology for the school of medicine.

Dr. Naritoku is board certified in neurology and clinical neurophysiology by the American Board of Psychiatry and Neurology, and is board certified by the American Board of Clinical Pharmacology.

Dr. Naritoku received his medical degree from Chicago Medical School and completed his internship in internal medicine at the University of Illinois in Chicago. He completed neurology residency training at Washington University in St. Louis. Following his residency, he completed a neuropharmacology and epilepsy fellowship also at Washington University.

The American Board of Clinical Pharmacology was established with the cooperation of the American College of Clinical Pharmacology, the American Society for Clinical Pharmacology and Therapeutics, and the American Society for Pharmacology and Experimental Therapeutics. The major objectives of the ABCP are: to evaluate the training credentials, the scientific research and teaching accomplishments of individuals,

to prepare and administer examinations for individual certification in clinical and applied pharmacology, and to register and accredit training programs in clinical pharmacology.

No comments:

Post a Comment